focus -WSS

focus

author：knowledge 2025-09-02 08:18:12 - browse：559

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： What causes an itch? Researchers may have solved the mystery

leisure time

WSS

Hormonal contraceptives don’t actually treat endometriosis

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Sanders wants to replace patents with prizes for drug inventions

Judge denies Trump's request for new trial in E. Jean Carroll case

Dementia risk linked to living in disadvantaged areas: Study

Leukemia patients are helped by Syndax's new type of therapy

focus

focus

explore

Medical leaders decry Supreme Court decision on affirmative action

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

After affirmative action ruling, medical educators look to 'holistic review'

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Guidelines to prevent youth baseball injuries need more muscle

Dementia risk linked to living in disadvantaged areas: Study

New air purifier tech could be key to improving indoor air quality

Delta passengers in Vegas fall sick while waiting on flight in triple

How to save PrEP access — and even expand it

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

entertainment

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

There’s a way to spot data fakery. All journals should be using it

Chemotherapy shortages won’t get better under Biden’s latest plan

Judge denies Trump's request for new trial in E. Jean Carroll case

Patients' immediate access to test results puts radiologists in a bind

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

hotspot

hotspot

leisure time

entertainment